Zacks Investment Research
24 Sept 2026, 22:51 UTC · 1h ago
Verdict
Headline takes no side. We score VRTX +0.20 across four claims — slightly bullish.
+0.20slightly bullish
More positive than 53% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Vertex Pharmaceuticals is expected to report upcoming quarterly revenue of $3.4 billion, representing a 10.43% increase from the prior-year quarter.
Priced inconsensus estimate for upcoming earnings
So whatA beat on this top-line figure would be necessary to reverse the 5.66% monthly price decline.
More positive than 64% of claims this week
The Zacks Consensus EPS estimate for the upcoming quarter is $4.84, a 0.83% increase year-over-year.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inconsensus estimate for upcoming earnings
So whatThe slim 0.83% growth suggests flat earnings growth heading into the next print.
More positive than 51% of claims this week
The Zacks Consensus EPS estimate for Vertex Pharmaceuticals has shifted 1.04% downward over the past month.
Priced intrend over the past month
So whatDownward revisions typically precede negative price action or a lower multiple.
More negative than 70% of claims this week
Vertex Pharmaceuticals is currently trading at a Forward P/E ratio of 27.38, which is a premium to the industry average of 25.2.
Priced incurrent valuation analysis
So whatThe company trades at a ~8.6% premium to peers, increasing sensitivity to any earnings miss.
More negative than 65% of claims this week
Which stocks this story touches
More positive than 53% of ticker scores this week
The company saw a daily price increase and has positive projected revenue and EPS growth for the upcoming year.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
VRTX hasn't traded since this ran. Last close $522.38 (Sep 24); the reaction starts at the next open.
VRTX chart →
